ASXL1 and ASXL2 mutations occur occasionally (approximately 10%) and frequently (10–30%) in AML with t(8;21)/RUNX1-RUNX1T1, respectively [12, 48–50]. This evidence concerns the gene ASXL2 and acute myeloid leukemia.